Immunosuppressive medication nonadherence is variable among older kidney transplant recipients and is a problem in African American recipients despite the severe consequences of this behavior. Many factors place older African American recipients at risk for medication nonadherence.
Objective
To provide an overview of interventions to enhance immunosuppressive medication adherence in older African American kidney transplant recipients using a culturally responsive model. Culturally sensitive, innovative, and transformation interventions are discussed. Situations when each intervention would be most and least appropriate are described.
Conclusion
Moving culturally appropriate interventions forward into practice and testing their effectiveness in improving adherence outcomes in vulnerable, older African American kidney transplant recipients is a worthy practice and research goal for transplant nursing.
Get full access to this article
View all access options for this article.
References
1.
Tripp-ReimerTChoiEKelleyLEnsleinJ. Cultural barriers to care: Inverting the problem. Diabetes Spectrum. Winter 2001;14:13–22.
2.
StegmayerPLovrienFCSmithMBKellerTGohdesDM. Designing a diabetes nutrition education program for a Native American community. Diabetes Educ. January-February 1988;14:64–66.
3.
SchwabRSimmonsR. Collaboration in action. Nurs Connection. Spring 1989;2:35–42.
4.
HeathGWWilsonRHSmithJLeonardBE. Community-based exercise and weight control: Diabetes risk reduction and glycemic control in Zuni Indians. Am J Clin Nutr.1991;53:1642S–1646S.
HarrisMBDavisSMFordVLTsoH. The checkerboard cardiovascular curriculum: A culturally oriented program. J Sch Health.1988;58:104–107.
7.
HoodVLKellyBMartinezCShumanSSecker-WalkerR. A Native American community initiative to prevent diabetes. Ethn Health.1997;2:277–285.
8.
Tom-OrmeL. Chronic disease and the social matrix: A Native American diabetes intervention. Recent Adv Nurs.1988;22:89–109.
9.
AuslanderWFHaire-JoshuDHoustonCAFisherEBJr. Community organization to reduce the risk of non-insulin dependent diabetes among low-income African American women. Ethn Dis.1992;2:176–184.
10.
BarrettBVavasourHParfreyP. The relationship of affect to physical symptoms in renal transplant recipients. Transplant Proc.1989;21:3353–3354.
11.
HarrisLELuftFCRudyDWTierneyWM. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis.1993;21:161–166.
12.
HathawayDBarrMLGhobrialRM. The PORTEL registry: Overview and selected findings. Prog Transplant.2003;13(suppl):3–13.
13.
ManninenDLEvansRWDuganMK. Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. In: TerasakiP, ed. Clinical Transplantation.Los Angeles, Calif: UCLA Tissue Typing Laboratory; 1991:193–203.
14.
MendezRAswadSDessoukiACicciarelliJMendezRG. Costs and financing of kidney transplantation in the United States. Transplant Proc.1992;24:2127–2128.
15.
Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1995–2004.Rockville, Md; Richmond, Va; Ann Arbor, Mich: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, United Network for Organ Sharing, University Renal Research and Education Association; 2005.
16.
De GeestSAbrahamIDunbar-JacobJVanhaeckeJ. Behavioral strategies for long-term survival of transplant recipients. In: MetryJMeyerU, eds. Drug Regimen Compliance: Issues in Clinical Trials and Patient Management.Chichester, NY: John Wiley & Sons; 1999:163–180.
17.
SabateE. Adherence to long-term therapies: Evidence for action.Geneva, Switzerland: World Health Organization; 2003:1–211.
18.
BosworthHB. Medication treatment adherence. In: BosworthHBOddoneEZWeinbergerM, eds. Patient Treatment Adherence: Concepts, Interventions, and Measurement.Mahwah, NJ: Lawrence Erlbaum Associates; 2006:147–194.
19.
ClaxtonAJCramerJPierceC. A systematic review of the associations between dose regimens and medication compliance. Clin Ther.2001;23:1296–1310.
20.
De GeestSBorgermansLGemoetsH. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation.1995;59:340–347.
21.
IsaacsRBNockSLSpencerCE. Racial disparities in renal transplant outcomes. Am J Kidney Dis.1999;34:706–712.
22.
KileyDJLamCSPollakR. A study of treatment compliance following kidney transplantation. Transplantation.1993;55:51–56.
23.
SchweizerRTRovelliMPalmeriDVosslerEHullDBartusS. Noncompliance in organ transplant recipients. Transplantation.1990;49:374–377.
24.
GastonRSHudsonSLWardMJonesPMaconR. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc.1999;31(4A):21S–23S.
25.
RovelliMPalmeriDVosslerEBartusSHullDSchweizerR. Noncompliance in organ transplant recipients. Transplant Proc.1989;21(1 pt 1):833–834.
26.
DidlakeRHDreyfusKKermanRHVan BurenCTKahanBD. Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc.1988;20(3suppl 3):63–69.
27.
WengFLIsraniAKJoffeMM. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol.2005;16:1839–1848.
28.
SiegalBRGreensteinSM. Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans. Adv Ren Replace Ther.1997;4:46–54.
29.
RyanAA. Medication compliance and older people: A review of the literature. Int J Nurs Stud.1999;36:153–162.
30.
McGrawCDrennanV. Self-administration of medicine and older people. Nurs Stand. January 2001;15:33–36.
31.
MoonsPVanrenterghemYvan HooffJP. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: A multicenter study. Transpl Int.2003;16:653–664.
DiMatteoMRGiordaniPJLepperHSCroghanTW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care.2002;40:794–811.
34.
FrazierPADavis-AliSHDahlKE. Correlates of noncompliance among renal transplant recipients. Clin Transplant.1994;8:550–557.
35.
RaizLRKiltyKMHenryMLFergusonRM. Medication compliance following renal transplantation. Transplantation.1999;68:51–55.
36.
HongJHSumraniNDelaneyVDavisRDibenedettoAButtKM. Causes of late renal allograft failure in the ciclosporin era. Nephron.1992;62:272–279.
37.
DouglasSBlixenCBartucciR. Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. J Transpl Coord. June 1996;6:53–58.
38.
ShoskesDAAvelinoLBarbaLSenderM. Patient death or renal graft loss within 3 yr of transplantation in a county hospital: Importance of poor initial graft function. Clin Transplant.1997;11:618–622.
39.
NevinsTEKruseLSkeansMAThomasW. The natural history of azathioprine compliance after renal transplantation. Kidney Int.2001;60:1565–1570.
40.
YoungCJGastonRS. Renal transplantation in black Americans. N Engl J Med.2000;343:1545–1552.
41.
RoterDLHallJAMeriscaRNordstromBCretinDSvarstadB. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care.1998;36:1138–1161.
42.
HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHP. Interventions to enhance medication adherence [systematic review]. Cochrane Database Syst Rev.2005 Oct 19;(4):CD000011.
43.
PetersonAMTakiyaLFinleyR. Meta-analysis of trials of interventions to improve medication adherence. Am J Health System Pharm.2003;60:657–665.
44.
RussellCConnVJantarakuptP. Older adult medication compliance: Integrated review of randomized controlled trials. Am J Health Behavior. In press.
45.
EngelGL. The need for a new medical model: A challenge for biomedicine. Science.1977;196:129–136.
46.
KleinmanA. The Illness Narratives: Suffering, Healing, and the Human Condition.New York, NY: Basic Books; 1988.
47.
LeventhalHDiefenbachMLeventhalEA. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Ther Res.1992;16:143–163.
48.
SchoenbergN. A convergence of health beliefs: An “ethnography of adherence” of African American rural elders with hypertension. Hum Organ.1997;56:174–181.
49.
Hueurtin-RobertsSReisinE. Folk models of hypertension among black women: Problems in illness management. In: CoreilJMullD, eds. Anthropology and Primary Health Care.Boulder, Colo: Westview Press; 1990:222–244.
50.
KleinmanAEisenbergLGoodB. Culture, illness, and care: Clinical lessons from anthropologic and cross-cultural research. Ann Intern Med.1978;88:251–258.
Banks-WallaceJ. Talk that talk: Storytelling and analysis rooted in African American oral tradition. Qual Health Res.2002;12:410–426.
53.
MessinaCJRussellCLEwigmanAWardCMefrakisL. Teaching patients about kidney transplantation: Documentation. Prog Transplant.2000;10:169–176.
54.
StefanichCAWitmerJMYoungBD. Development, adaptation, and implementation of a cardiovascular health program for Alaska native women. Health Promotion Practice.2005;6:472–481.
55.
RobbinsBRauschKJGarciaRIPrestwoodKM. Multicultural medication adherence: A comparative study. J Gerontol Nurs. July 2004;30:25–32.
56.
StevensonJS. Health promotion for chronically ill elders. In: SwansonEATripp-ReimerT, eds. Chronic Illness and the Older Adult.New York, NY: Springer; 1997:30–61.
57.
BrangmanSA. African-American elders: Implications for health care providers. Clin Geriatr Med.1995;11:15–23.
MoonsPDe GeestSAbrahamIVan CleemputJVanhaeckeJ. Symptom experience associated with maintenance immunosuppression after heart transplantation: Patients' appraisal of side effects. Heart Lung.1998;27:315–325.
60.
ReidB. “It's like you're down on a bed of affliction”: Aging and diabetes among Black Americans. Soc Sci Med.1992;34:1317–1323.
